ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ECS Named Prime on $500M ARPA-H IDIQ

Company to provide advisory and assistance services for biomedical and health research

ECS, a leader in advanced technology, science, and engineering solutions and an ASGN (NYSE: ASGN) brand, has been named a prime contractor on a five-year, $500M indefinite delivery/indefinite quality (IDIQ) contract from the Department of Health and Human Services (HHS) Advanced Research Projects Agency for Health (ARPA-H).

The Strategic Technical ARPA-H Talent Support (STATS) contract vehicle calls for systems engineering, technical advisory support, and other professional services including financial management and program management. STATS is a new contract for ECS.

Established in 2022, ARPA-H supports the development of high-impact research to drive biomedical and health breakthroughs and deliver transformative, sustainable, and equitable health solutions for all Americans.

Under the contract, ECS will support ARPA-H in managing pivotal investments in breakthrough technologies and broadly applicable platforms, capabilities, resources, and solutions. This work will directly support the biomedical and health research programs at the heart of ARPA-H’s mission. It will also enable ARPA-H to leverage ECS services and solutions across their forward-facing mission offices and support offices.

“ECS has decades of experience in two key areas that position us to support ARPA-H's mission. First, we’ve served as a prime contractor with the Defense Advanced Research Projects Agency, which pioneered the federal “ARPA Model” used by ARPA-H today. Second, we’ve acted as a health modernization agent, directly supporting transformational programs across DHA, VA, HHS, and innovative programs across the National Institutes of Health,” said John Heneghan, president of ECS. “We’re thrilled to have this opportunity to deliver inaugural contract services to a new federal agency, while also expanding our ability to deliver health modernization expertise to the frontlines of biotech and health innovation.”

“We are thrilled to support ARPA-H as it takes on the most urgent challenges in our health ecosystem,” said Asad Akhtar, vice president of Health Analytics, Automation, and Artificial Intelligence at ECS. “These challenges range from escalating rates of chronic disease to inequitable access to high-quality health care, to the rise of antimicrobial resistance.”

About ECS

ECS, ASGN’s federal government segment, delivers advanced solutions in cybersecurity, data and artificial intelligence (AI), cloud, application and IT modernization, science, and engineering. The company solves critical, complex challenges for customers across the U.S. public sector, defense, intelligence, and commercial industries. ECS maintains partnerships with leading cloud, cybersecurity, and AI/ML providers and holds specialized certifications in their technologies. Headquartered in Fairfax, Virginia, ECS has more than 3,800 employees throughout the United States. For more information, visit ECStech.com.

About ASGN Incorporated

ASGN Incorporated (NYSE: ASGN) is a leading provider of IT services and solutions across the commercial and government sectors. ASGN helps corporate enterprises and government organizations develop, implement, and operate critical IT and business solutions through its integrated offerings. For more information, please visit asgn.com.

“We’re thrilled to have this opportunity to deliver inaugural contract services to a new federal agency, while also expanding our ability to deliver health modernization expertise to the frontlines of biotech and health innovation.”

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.